EUVIMEDEUVIMED entdecken
Crossref

Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis Therapy

Lang Yao iD, Na Yang, Wei Zhou, Mahmood Hassan Akhtar, Weiping Zhou, Chang Liu, Shuang Song, Ying Li, Wenzhao Han, Cong Yu iD

Advanced Healthcare Materials · 2023

DOI: 10.1002/adhm.202300871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Lang Yao und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, P. R. …. Hauptthemen laut MEDLINE: Dihydroorotate Dehydrogenase, Ferroptosis, Neoplasms. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ferroptosis is a form of programmed cell death and plays an important role in many diseases. Dihydroorotate dehydrogenase (DHODH) and glutathione peroxidase 4 (GPX4) play major roles in cell resistance to ferroptosis. Therefore, inactivation of these proteins provides an excellent opportunity for efficient ferroptosis‐based synergistic cancer therapy. In this study, a multifunctional nanoagent (BPN pro ) containing a GPX4 targeting boron dipyrromethene (Bodipy) probe (BP) and a DHODH targeting proteolysis targeting chimera (PROTAC) is reported. BPN pro is prepared using a nanoprecipitation method in the presence of a thermoresponsive liposome, where BP is encapsulated inside and the cathepsin B (CatB)‐cleavable PROTAC peptide (DPCP) is modified on the outer surface. In the presence of near‐infrared (NIR) photoirradiation, BPN pro is melted and BP is released in tumor cells. Subsequently, BP inhibits the activity of GPX4 by covalently bonding with the selenocysteine at the enzyme active site. In addition, DPCP achieves sustained degradation of DHODH upon activation by CatB overexpressed in the tumor. The synergistic deactivation of GPX4 and DHODH induces extensive ferroptosis and subsequent cell death. In vivo and in vitro studies clearly show that the proposed ferroptosis therapy provides excellent antitumor effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dihydroorotate DehydrogenaseFerroptosisNeoplasmsHumansBoronPorphobilinogenPhospholipid Hydroperoxide Glutathione Peroxidase

Stichwörter der Autor:innen

bodipy probesdihydroorotate dehydrogenase depletionferroptosis therapyglutathione peroxidase 4 inhibitionproteolysis targeting chimera

Substanzen

BoronDihydroorotate DehydrogenasedipyrromethenePorphobilinogenGPX4 protein, humanPhospholipid Hydroperoxide Glutathione Peroxidase

Autor:innen und Institutionen

  • State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, P. R. China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, 230026, P. R. China.

ORCID-Profile: Lang Yao, Cong Yu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yao, L., Yang, N., Zhou, W., Akhtar, M. H., Zhou, W., Liu, C., Song, S., Li, Y., Han, W., & Yu, C. (2023). Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300871

Vancouver

Yao L, Yang N, Zhou W, Akhtar MH, Zhou W, Liu C, et al. Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis Therapy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300871

BibTeX
@article{Yao2023,
  author = {Yao, Lang and Yang, Na and Zhou, Wei and Akhtar, Mahmood Hassan and Zhou, Weiping and Liu, Chang and Song, Shuang and Li, Ying and Han, Wenzhao and Yu, Cong},
  title = {Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  doi = {10.1002/adhm.202300871}
}
Kostenlos starten →